Wendy Stock to CD56 Antigen
This is a "connection" page, showing publications Wendy Stock has written about CD56 Antigen.
Connection Strength
0.021
-
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J Clin Invest. 2000 Jul; 106(1):117-24.
Score: 0.011
-
A phase II trial of interleukin-2 in myelodysplastic syndromes. Br J Haematol. 1998 Apr; 101(1):205-7.
Score: 0.010